GlaxoSmithKline is under pressure from shareholders ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...
GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Teva Pharmaceutical Industries Ltd. ADR 1.52% $19.75B ...
Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley believes her company can … ...
With every intricate detail, Jio Studios’ new logo embodies its mission: “Make in India, Show the World.” With just two colours Black and Gold until the last frame, the logo is timeless and ...
The three big airports that serve New York City have proposed allowing concession prices to rise and adding a surcharge to cover higher wages and improved worker benefits. By Patrick McGeehan ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback